Evidence map›Paper›PMID 41971634›Full record

ArticleJCEM case reports2026

A case of thyroid hormone resistance with coincidental pituitary macroadenoma.

Yi-An Pan, Liyan Wang, Usman Hammawa Malabu, Swetha Rangaswamaiah

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yi-An PanDepartment of Endocrinology and Diabetes, Townsville University Hospital, Townsville, Queensland 4814, Australia.ORCID https://orcid.org/0000-0001-8352-6179
Liyan WangDepartment of Endocrinology and Diabetes, Townsville University Hospital, Townsville, Queensland 4814, Australia.ORCID https://orcid.org/0009-0005-0003-2090
Usman Hammawa MalabuDepartment of Endocrinology and Diabetes, Townsville University Hospital, Townsville, Queensland 4814, Australia.ORCID https://orcid.org/0000-0003-4899-7228
Swetha RangaswamaiahDepartment of Endocrinology and Diabetes, Townsville University Hospital, Townsville, Queensland 4814, Australia.ORCID https://orcid.org/0000-0001-5691-1821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central hyperthyroidism can be a diagnostic challenge, and most commonly arises from a thyrotropin-secreting pituitary adenoma (TSHoma) or thyroid hormone resistance (RTH). Assay interference from heterophile antibodies can also produce spurious biochemical results that mimic these conditions. Accurate distinction between these entities is essential as management strategies differ substantially. We present the case of a 35-year-old man with central hyperthyroidism in the context of a large pituitary macroadenoma, initially suggestive of a TSHoma. Comprehensive biochemical evaluation, dynamic testing and subsequent genetic testing, identified a heterozygous autosomal dominant

Indexed as

hyperthyroidismhypothalamic-pituitarypituitary tumors/massthyroidthyroid laboratory testingthyroid tumor/goiter/mass

Identifiers

PMID41971634
PMCPMC13069481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.